awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33408056-91643A81-E1D1-4602-AA3B-564E840FB0E3
Q33408056-91643A81-E1D1-4602-AA3B-564E840FB0E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33408056-91643A81-E1D1-4602-AA3B-564E840FB0E3
Phase II study of bortezomib-dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma
P2860
Q33408056-91643A81-E1D1-4602-AA3B-564E840FB0E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33408056-91643A81-E1D1-4602-AA3B-564E840FB0E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7853e33ab532078ea2478682959a163f289cd44
P2860
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.